Filing Details
- Accession Number:
- 0001600132-16-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-18 13:46:32
- Reporting Period:
- 2016-05-17
- Filing Date:
- 2016-05-18
- Accepted Time:
- 2016-05-18 13:46:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1600132 | Bellerophon Therapeutics Inc. | BLPH | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1500241 | M Jonathan Peacock | C/O Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ 07059 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-17 | 5,000 | $1.37 | 222,702 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $1.33 to $1.37 per share. The reporting person hereby undertakes upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.